(Q70774500)
Statements
Interim results of a phase II multicenter clinical trial evaluating the activity of a therapeutic allogeneic melanoma vaccine (theraccine) in the treatment of disseminated malignant melanoma (English)
Elliott GT
McLeod RA
Perez J
Von Eschen KB